NEXAGON

· Glaukos Corporation

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for NEXAGON, covering 2009-01-08 to 2025-07-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED [Phase 2]

See pricing